c-Myc inhibition decreases CIP2A and reduces BCR-ABL1 tyrosine kinase activity in chronic myeloid leukemia. [electronic resource]
Producer: 20151022Description: e179-82 p. digitalISSN:- 1592-8721
- Autoantigens -- metabolism
- Cell Line, Tumor
- Enzyme Activation -- drug effects
- Fusion Proteins, bcr-abl -- metabolism
- Humans
- Intracellular Signaling Peptides and Proteins
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- diagnosis
- Membrane Proteins -- metabolism
- Proto-Oncogene Proteins c-myc -- antagonists & inhibitors
- RNA Interference
- RNA, Small Interfering -- genetics
- Thiazoles -- pharmacology
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.